Juggat Pharma to set up 2 plants in FY22 to boost nutraceutical production

Seeing a sharp rise in the demand for its suite of nutraceutical products post the Covid-19 outbreak, Bengaluru based Juggat Pharma will be investing Rs 60 crore in two new manufacturing units in FY22 to scale up production in Uttar Pradesh and Madhya Pradesh. The company is part of the over 50-year-old Jagdale Industries.
 

Its flagship product Mulmina, an antioxidant-rich immune boosting drink, has seen traction of over 150 per cent since April.

“This product was launched in 2018, and because we were one of the first players who were in the market, we had the first mover advantage and we